Evidence map›Paper›PMID 36550121›Full record

ReviewNature reviews. Disease primers2022

Hazardous drinking and alcohol use disorders.

James MacKillop, Roberta Agabio, Sarah W Feldstein Ewing, Markus Heilig, John F Kelly, Lorenzo Leggio, Anne Lingford-Hughes, Abraham A Palmer, Charles D Parry, Lara Ray and 1 more

Erratum issuedOpen access · bronzeAbstract readReview
In one paragraph

Review in Nature reviews. Disease primers, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 128 papers, 9 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
128citing papers in PubMed, 9 pooled it
25.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

128 citing papers in PubMed, 9 syntheses or guidelines pooled it, 180 citations in OpenAlex.

  1. Pooled it
  2. Guideline
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Disulfiram for the treatment of cocaine dependence.The Cochrane database of systematic reviews · 2024
    Pooled it
  8. Pooled it
  9. Baclofen for alcohol use disorder.The Cochrane database of systematic reviews · 2023
    Pooled it
  10. Trial
  11. Trial
  12. Trial
  13. Trial
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article

68 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 11 institutions in 9 countries.

James MacKillopPeter Boris Centre for Addictions Research, McMaster University & St. Joseph's Healthcare Hamilton, Hamilton, ON, Canada. jmackill@mcmaster.ca.ORCID http://orcid.org/0000-0002-8695-1071
Roberta AgabioDepartment of Biomedical Sciences, Section of Neuroscience and Clinical Pharmacology, University of Cagliari, Cagliari, Italy.ORCID http://orcid.org/0000-0001-7395-6845
Sarah W Feldstein EwingDepartment of Psychology, University of Rhode Island, Kingston, RI, USA.
Markus HeiligCenter for Social and Affective Neuroscience, Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.
John F KellyRecovery Research Institute and Department of Psychiatry, Massachusetts General Hospital & Harvard Medical School, Boston, MA, USA.
Lorenzo LeggioClinical Psychoneuroendocrinology and Neuropsychopharmacology Section, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, MD, USA.
Anne Lingford-HughesDivision of Psychiatry, Imperial College London, London, UK.
Abraham A PalmerDepartment of Psychiatry & Institute for Genomic Medicine, University of California San Diego, La Jolla, CA, USA.
Charles D ParryAlcohol, Tobacco and Other Drug Research Unit, South African Medical Research Council, Cape Town, South Africa.
Lara RayDepartments of Psychology and Psychiatry, University of California, Los Angeles, Los Angeles, CA, USA.
Jürgen RehmInstitute for Mental Health Policy Research, Campbell Family Mental Health Research Institute, PAHO/WHO Collaborating Centre, Centre for Addiction and Mental Health, Toronto, Canada.ORCID http://orcid.org/0000-0001-5665-0385
Central and North West London NHS Foundation Trust · GBCentre for Addiction and Mental Health · CAHarvard University · USHomewood Research Institute · CALinköping University · SENational Institutes of Health · USSouth African Medical Research Council · ZAUniversity of Cagliari · ITUniversity of California, Los Angeles · USUniversity of California San Diego · USUniversity of Rhode Island · US

Funding

Sequencing CoreP50DA037844 · NIDA · UNIVERSITY OF CHICAGO · PI SOLBERG WOODS, LEAH CATHERINE · 2014 to 2023
$27.4M
UCLA Training Program in Translational Neuroscience of Drug Abuse (TNDA)T32DA024635 · NIDA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI LARA A. RAY, Kate M Wassum · 2008 to 2026
$6.2M
A Framework for Translating Polygenic Findings Related to Alcohol Use Disorder Across SpeciesR01AA029688 · NIAAA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Hae Kyung Im, Abraham A Palmer · 2022 to 2026
$3.1M
Investigating impulsivity and social network changes as novel mechanisms of behavior change for Alcoholics Anonymous' (AA) positive effectsR01AA025849 · NIAAA · MASSACHUSETTS GENERAL HOSPITAL · PI KELLY, JOHN F., MACKILLOP, JAMES · 2018 to 2022
$2.7M
A Novel Pharmacotherapy for Alcoholism: Evaluation of Reward, Aversion, Compulsivity, Withdrawal & ReinstatementR01AA026281 · NIAAA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI PALMER, ABRAHAM A · 2018 to 2022
$2.0M
Mentoring in Patient-Oriented Addiction ResearchK24AA022136 · NIAAA · MASSACHUSETTS GENERAL HOSPITAL · PI KELLY, JOHN F. · 2014 to 2023
$1.8M
The role of religiosity, socioeconomic status and the relationship between behavioral economic variables as mediators of negative alcohol-related consequences in African American emerging adultsR01AA024930 · NIAAA · UNIVERSITY OF MEMPHIS · PI MACKILLOP, JAMES, MURPHY, JAMES G. · 2017 to 2021
$1.6M
Clinical Neuroscience of Alcoholism: Integrating Neuroscience and Clinical TrialsK24AA025704 · NIAAA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI LARA A. RAY · 2018 to 2026
$1.3M
Using Neuroeconomics to Understand Alcohol Overvaluation in Alcohol Use DisorderR01AA025911 · NIAAA · UNIVERSITY OF GEORGIA · PI MACKILLOP, JAMES, SWEET, LAWRENCE H · 2018 to 2022
$1.3M
Deriving a de novo adolescent addiction treatment from developmental brain dataK24AA026876 · NIAAA · UNIVERSITY OF RHODE ISLAND · PI Sarah W. Feldstein Ewing · 2018 to 2026
$1.3M
Behavioral Economic Trajectories of Alcohol Misuse in Emerging Adults: Neuroeconomic Augmentation via ElectroencephalographyR21AA027679 · NIAAA · UNIVERSITY OF MEMPHIS · PI MACKILLOP, JAMES, MURPHY, JAMES G. · 2020 to 2021
$374k
NIAAA NIH HHS K24 AA022136NIAAA NIH HHS K24 AA025704NIAAA NIH HHS K24 AA026876NIAAA NIH HHS R01 AA024930NIAAA NIH HHS R01 AA025849NIAAA NIH HHS R01 AA025911NIAAA NIH HHS R01 AA026281NIAAA NIH HHS R01 AA029688NIAAA NIH HHS R21 AA027679NIDA NIH HHS P50 DA037844NIDA NIH HHS T32 DA024635
6 · The paper itself

Abstract

Alcohol is one of the most widely consumed psychoactive drugs globally. Hazardous drinking, defined by quantity and frequency of consumption, is associated with acute and chronic morbidity. Alcohol use disorders (AUDs) are psychiatric syndromes characterized by impaired control over drinking and other symptoms. Contemporary aetiological perspectives on AUDs apply a biopsychosocial framework that emphasizes the interplay of genetics, neurobiology, psychology, and an individual's social and societal context. There is strong evidence that AUDs are genetically influenced, but with a complex polygenic architecture. Likewise, there is robust evidence for environmental influences, such as adverse childhood exposures and maladaptive developmental trajectories. Well-established biological and psychological determinants of AUDs include neuroadaptive changes following persistent use, differences in brain structure and function, and motivational determinants including overvaluation of alcohol reinforcement, acute effects of environmental triggers and stress, elevations in multiple facets of impulsivity, and lack of alternative reinforcers. Social factors include bidirectional roles of social networks and sociocultural influences, such as public health control strategies and social determinants of health. An array of evidence-based approaches for reducing alcohol harms are available, including screening, pharmacotherapies, psychological interventions and policy strategies, but are substantially underused. Priorities for the field include translating advances in basic biobehavioural research into novel clinical applications and, in turn, promoting widespread implementation of evidence-based clinical approaches in practice and health-care systems.

Indexed as

AlcoholismChildHumans

Identifiers

PMID36550121
PMCPMC10284465
OpenAlexW4312194865

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.